Hydroxyapatite as a Functional Ingredient

The mineral your teeth
are already made of

An independent research reference for formulation chemists, R&D procurement teams, and ingredient buyers. Covering the science, mechanisms, and commercial applications of hydroxyapatite — with a focus on functional-grade material quality.

97%
of tooth enamel is composed of hydroxyapatite
70%
of human bone mineral content is hydroxyapatite
50+
years of peer-reviewed research since NASA studies (1970s)
3
distinct commercial application pillars in personal care
Explore
01

What is Hydroxyapatite?

The primary mineral component of human teeth and bone — and one of the most biocompatible materials known to formulation science.

The body's own structural mineral

Hydroxyapatite (Ca₁₀(PO₄)₆(OH)₂) is a calcium phosphate mineral that forms the inorganic matrix of human bones and teeth. It accounts for approximately 97% of tooth enamel and 65–70% of bone by weight. It is not a synthetic foreign material — it is the mineral your body already produces and maintains throughout your lifetime.

Research into synthetic hydroxyapatite began in earnest in the 1970s, when NASA studied calcium mineral loss in astronauts during spaceflight. This work established the foundation for what is now a well-characterised, extensively peer-reviewed ingredient with approval status in Japan, the EU (SCCS), and Canada for oral care applications.

The key advancement of the past two decades has been the production of nano-hydroxyapatite (nHAP) — particles sized 20–80 nm that match the scale of the crystalline structures found in natural enamel. At this size, the material can access the micro-defects in enamel that are the entry point for caries, staining, and sensitivity.

EU Safety Classification: The Scientific Committee on Consumer Safety (SCCS) has confirmed nano-hydroxyapatite is safe for use in oral care formulations at concentrations up to 29.5%. The EU maintains among the world's most stringent cosmetic ingredient standards.

02

Not all hydroxyapatite
performs the same

Source material and manufacturing process determine functional performance. This comparison documents the critical technical differences between general mineral-derived HAP and purpose-engineered functional-grade material.

Technical comparison: General mineral-derived hydroxyapatite vs Hydroxyapatite-LC. Covers raw material origin, manufacturing process, particle consistency, quality standard, purity control, GHS safety profile, designed application, and quality assurance.
Figure 01

Quality Beyond the Source: the critical difference lies not in the source rock, but in the precision of the manufacturing process and the purpose of the design. Functional-grade HAP for cosmetic and oral care applications requires particle consistency and quality oversight that general industrial-grade material does not provide.

03

Mechanisms of action
in oral care

Three independently documented mechanisms make hydroxyapatite a multi-functional oral care ingredient — addressing remineralisation, biofilm management, and sensitivity in a single material.

Mechanism 01

Remineralisation

Nano-HAP particles integrate into demineralised enamel zones, restoring the mineral matrix that acid erosion and brushing remove over time. Unlike fluoride, which converts hydroxyapatite to fluorapatite, nano-HAP deposits the same mineral the tooth is already composed of. Multiple RCTs confirm remineralisation efficacy comparable to sodium fluoride at equivalent concentrations.

Mechanism 02

Microbial adsorption

Hydroxyapatite adsorbs Streptococcus mutans (primary cariogenic pathogen) and Porphyromonas gingivalis (periodontitis-associated) via electrostatic surface binding. This physical removal mechanism — distinct from antibacterial chemistry — supports oral microbiome balance without disrupting beneficial flora. Research published in the Journal of Functional Biomaterials (2025) documents this mechanism specifically for eggshell-derived nHAP.

Mechanism 03

Dentine desensitisation

Nano-particle size (20–80 nm) enables access to exposed dentinal tubules — the pathways that transmit thermal and tactile stimuli to pulp nerves in sensitivity conditions. By occluding these tubules with biomimetic mineral, nano-HAP reduces sensitivity without chemical intervention. Clinical studies show statistically significant reduction in cold-air and tactile sensitivity at two and four weeks of use.

Mechanism 04

Surface whitening

The adsorption properties of hydroxyapatite extend to chromogenic compounds — pigment molecules from food and beverages that bind to enamel surface irregularities. HAP adsorbs these pigments and, through its enamel-smoothing effect, creates a surface that reflects light more uniformly. Systematic review of 17 studies (2023) concluded regular use of HAP-containing oral care products effectively whitens teeth.

Mechanism 05

Fluoride-alternative positioning

Hydroxyapatite has achieved formal regulatory approval as an anti-cavity active in Japan (since 1993) and recognition in the EU via SCCS safety assessment. For brands targeting fluoride-sensitive consumer segments — including natural oral care, children's products, and markets with fluoride restriction concerns — nano-HAP provides a documented efficacy alternative with a biocompatibility profile fluoride cannot match.

Mechanism 06

Formulation versatility

Nano-HAP is compatible with standard toothpaste, gel, mouthwash, and dental serum formulation platforms. Effective concentrations range from 1–10% depending on particle grade and intended application. Unlike bioactive glass alternatives, it does not require alkaline pH conditions and is stable across standard oral care formulation pH ranges. Suspension stability is maintained with standard rheology modifiers.

04

Microbial adsorption:
the deodorant mechanism

The same surface adsorption property that makes hydroxyapatite effective in oral care creates a novel, chemical-free mechanism for personal care — directly relevant to the aluminium-free deodorant reformulation challenge.

Hydroxyapatite-LC advanced microbial adsorption: physical mechanism, multi-functional formulation potential, broad-spectrum targeting, biocompatible mineral base, proven safety profile, safe for sensitive populations.

Physical capture, not chemical disruption

Body odour is primarily caused by the metabolic activity of specific bacteria — predominantly Staphylococcus epidermidis, Corynebacterium species, and Malassezia fungi — which convert odourless precursors in sweat into volatile malodorous compounds.

Conventional aluminium-based antiperspirants work by blocking eccrine gland function. Conventional deodorants use fragrance masking, antimicrobial agents (triclosan, alcohol), or pH adjustment. All three approaches involve chemical intervention with the microbiome.

Hydroxyapatite offers a fourth mechanism: physical adsorption of the bacteria themselves onto the mineral surface, reducing the bacterial population available to generate odour compounds. This is the same mechanism that underpins its oral biofilm effect — extended to the body care context.

  • Target Odour-causing bacteria (Corynebacterium, Staphylococcus) and fungi (Malassezia) adsorbed to HAP surface via electrostatic binding
  • Application Aluminium-free deodorant sticks, roll-ons, body mists, foot care, acne-targeting skincare
  • Safety GHS-confirmed non-hazardous. Already used in food and medical nutrition. Safe for sensitive populations including pregnancy and children
  • Formulation Compatible with standard anhydrous and emulsion deodorant bases. Particle size 20–80 nm — no grittiness at functional concentrations
Request application data →
05

Three commercial
application pillars

Hydroxyapatite-LC addresses three independently validated market opportunities, each with distinct buyer profiles and formulation requirements.

06

Hydroxyapatite-LC:
Technical overview

Purpose-engineered for cosmetic and oral care applications. Manufactured under Japanese Quasi-Drug Raw Material standards with complete lot traceability.

Precision manufacturing for functional applications

The difference between industrial hydroxyapatite and functional-grade nano-HAP is not source material — it is process control. Hydroxyapatite-LC is produced via a patented, highly controlled manufacturing process that delivers consistent particle morphology, minimal lot-to-lot variation, and a safety profile documented to Japanese Quasi-Drug standards.

For formulation teams building claims-substantiated products, this documentation is not incidental — it is the foundation of the regulatory dossier.

Made in Japan · Patent Protected
Material type Nano-hydroxyapatite (nHAP) — calcium phosphate mineral
Particle size 20–80 nm (nano-range, matched to enamel crystal scale)
Origin Mineral-derived (limestone), Japan
Manufacturing Patented controlled process — consistent morphology, minimal lot variation
Quality standard Japanese Quasi-Drug Raw Material Standard
GHS safety Non-hazardous — confirmed classification
EU SCCS status Safe in oral care up to 29.5% concentration
Application design Specifically optimised for cosmetic & oral care use — not general industrial
Documentation Certificate of analysis, safety data sheet, regulatory reference file available on request
Sample availability 50–100g evaluation samples available to qualified R&D laboratories
Technical Enquiries

Request data for your formulation team

Technical data sheets, safety documentation, regulatory reference files, and evaluation samples (50–100g) are available to qualified R&D laboratories and formulation OEMs. No purchase commitment required for evaluation.

Evaluation samples and full documentation packages sent within 3 business days. Commercial enquiries handled by Technicity Pte. Ltd. (Singapore).